Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT03409523 for Diabete Mellitus is completed. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes 30 Observational
Clinical Trial NCT03409523 was an observational study for Diabete Mellitus that is now completed. The study started on January 8, 2018, with plans to enroll 30 participants. Led by NYU Langone Health, the expected completion date was July 3, 2019. The latest data from ClinicalTrials.gov was last updated on July 8, 2019.
Brief Summary
This study will develop a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module will incorporate effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely guidelines; this generally involves less aggressive targets for HbA1c, and reductions of medications other than metformin.
The im...
Show MoreDetailed Description
The primary objective of this study is to develop a scalable, EHR customization toolkit that applies BE insights to promote appropriate diabetes care in older adults based on the American Geriatric Society's Choosing Wisely Guideline, as to assess the acceptability of the resulting module.
Official Title
An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes
Conditions
Diabete MellitusPublications
Scientific articles and research papers published about this clinical trial:Other Study IDs
- 17-01308
NCT ID Number
Start Date (Actual)
2018-01-08
Last Update Posted
2019-07-08
Completion Date (Estimated)
2019-07-03
Enrollment (Estimated)
30
Study Type
Observational
Status
Completed
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Compliance with Choosing Wisely guidelines measured by number of reductions of medications | The implementation of the module will ultimately be triggered by medication prescribing in EPIC. | 60 Months |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Usability measured by module user testing with direct observation and semi structured interviews | 60 Months |
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
21 Years
Eligible Sexes
All
- Providers in NYU outpatient primary care, geriatrics, or endocrine clinics at NYU who care for older adults with diabetes
- None
NYU Langone HealthNo contact data.
1 Study Locations in 1 Countries
New York
New York University School of Medicine, New York, New York, 10016, United States